TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
ILMN

Illumina Inc

Healthcare · Diagnostics & Research

264.60$ -1.2% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Cash Flow

Illumina Inc (ILMN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 201 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Cash Flow ILMN
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
150 280 168 178 235 294 255 295 292 300 198 143 267 443 281 240 153 406 282 253 -272 282 172 125 -52 147 10 105 139 223 77 80 316 364 240 234 284 321 289 201 1,095
36 37 38 38 41 39 39 45 45 50 47 49 47 45 44 46 47 50 48 49 65 89 91 94 103 106 107 108 108 107 108 105 70 71 69 -69 67 67 69 70 273
35 27 50 39 34 41 48 50 48 47 51 48 46 49 39 16 61 78 67 80 509 98 92 91 83 100 93 106 87 94 96 112 83 79 73 -73 70 63 60 -60 133
40 79 -296 16 24 72 31 39 44 44 20 -78 69 94 100 28 12 -16 15 -23 -370 130 65 152 3,661 73 98 205 – – – – – – – – – – – – –
-50 49 71 -4.0 9.0 119 -20 3.0 5.0 -6.0 -107 -50 -92 55 -46 110 -95 104 62 32 -261 15 -65 405 -122 -14 10 26 1.0 78 -26 82 -56 2.0 -4.0 4.0 -56 -18 -1.0 1.0 -74
69 82 83 69 84 76 90 77 64 65 56 47 49 57 40 39 48 62 42 44 52 70 61 71 246 88 52 47 45 51 36 31 32 29 39 23 24 54 38 40 156
-341 -173 163 36 -97 -315 12 -536 -940 -349 988 79 -219 -104 -135 -320 -65 -33 1,376 3.0 -2,448 -580 -74 -165 -250 -102 -56 -37 -54 -85 -48 -41 -41 -48 -63 -49 -51 108 -366 -122 -431
3.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 – – – – – – – – – – – – – – – – 9.0 – – – – – – – – – – – – – –
-13 -136 -101 9.0 -75 -75 -198 1.0 -103 -98 -63 -142 -198 -63 -188 -142 -125 -281 31 -6.0 28 1.0 33 -5.0 -2.0 -35 -9.0 -3.0 -2.0 -26 -1.0 -1.0 -99 -17 -200 -370 -130 -42 -242 242 -172
4.0 4.6 -1.0 -1.0 -1.0 -2.0 -2.0 734 734 -1.0 -1.0 -549 – – – 961 961 961 961 -490 – – – – 991 991 -501 – – – – – -1,494 1,241 – – 0.0 -5.0 – – –
34 -163 -86 23 -5.0 -109 67 30 650 -153 -60 -549 -173 -115 -191 -143 -101 -331 968 -496 -394 -129 21 -5.0 28 956 -473 -3.0 -707 -26 35 -226 -332 -47 -195 -371 -115 -63 -251 -129 -558
-157 -60 246 238 135 -129 335 -216 2.0 -202 1,126 -327 -128 227 -51 -221 -9.0 49 2,623 -237 -3,116 152 119 -62 -289 1,011 -517 59 -626 121 60 -188 -51 258 -14 -179 116 368 -329 -49 106
82 199 85 109 151 218 165 218 228 235 142 96 218 386 241 201 105 344 240 209 -324 212 111 54 -298 59 -42 58 94 172 41 49 284 335 201 211 260 267 251 161 939

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?